Navigation Links
STAAR Surgical Generates Cash From Operations During Second Quarter
Date:8/3/2009

- 3,850 Change in pension liability 106 56 Other 112 (130) Changes in working capital, net of business acquisition: Accounts receivable (1,173) (2,716) Inventories 937 2,034 Prepaids, deposits and other current assets 381 (487) Accounts payable (645) (753) Other current liabilities 233 714 --- --- Net cash used in operating activities (162) (6,130) ---- ------ Cash flows from investing activities: Cash acquired in acquisition of Canon Staar, net of acquisition costs - 2,511 Acquisition of property and equipment (256) (415) Proceeds from sale of property and equipment 81 89 Proceeds from sale of short-term investments - 79 Restricted deposit with the Superior Court of Orange County (7,341) - Net change in other assets 5 (63) - --- Net cash provided by (used in) investing activities (7,511) 2,201 ------ ----- Cash flows from financing activities: Borrowings under lines of credit 630 3,800 Repayments of lines of credit - (1,900) Repayment of capital lease lines of credit (559) (419) Net proceed
'/>"/>
SOURCE STAAR Surgical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. STAAR Surgical to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
2. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
3. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
4. STAAR Surgical Announces Second Quarter 2009 Earnings Release Date And Conference Call
5. Richard A. Meier Appointed to STAAR Surgical Board of Directors
6. STAAR Surgical Completes Common Stock Offering
7. STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System
8. STAAR Surgical Announces First Quarter 2009 Earnings Release Date and Conference Call
9. STAAR Surgical Reports 14% Fourth Quarter Revenue Growth
10. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
11. STAAR Surgical Reports 33% Third Quarter Revenue Growth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)....G.Schwade,M.D.announcesthenewlyenhancedCyberKnife...CenterofMiami,( www.cyberknifemiami.com ). ,,...edintensedoseofradiationthatkillscancercellswithno...nlastfrom30minutestoonehour,andisusuallycompletedi...tCenterintheSoutheasternU.S.,theMiamifacilityhasle...
(Date:11/23/2009)... to treatment advances, study finds , , ...ntent of saliva changes as people age, and better ...simple test to diagnose and treat age-related dise...ins numerous proteins that play a role in digestio...ers are trying to find ways to use these proteins ...
(Date:11/23/2009)...the brain is regulated by a peptide known as C3a, ...into nerve cells and is also important for the mig..., reveals new research from the Sahlgrenska Academ...ugh the research has been carried out using mice a... for human beings, which could be given to patient...
(Date:11/23/2009)...partment of Agriculture (USDA) has awarded a two-y...rsity of Minnesota to complete sequencing the geno.... The funding will be used by the Turkey Genome Se...ing using next-generation sequencing platforms, as... functions in the final genome sequence by use of ...
(Date:11/23/2009)...Call/--AnnTaylorStoresCorp.announcedtodaythatitwil...sandGivingcampaign,aholidayfundraisingandawareness...armarksthethirdyearthatAnnTaylor,throughitsANNCARE...mpaignwhereweofferourshoppersanopportunitytohelpsa...hisholidayseason.ClientswhoshopatAnnTaylor,Loft,An...
Breaking Medicine News(10 mins):Health News:Turkey Genome Sequencing Consortium awarded $0.9 million from USDA 2Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2
...600 injuries were reported by the US consumer prod...n previously thought and raising concerns. These ...y are the target market for these wheeled shoes. T...crowded malls and playgrounds. Scott Wolfson...
... no good reason to deny insurers access to genetic...bate published in this weeks BMJ. Only if...nformation can we reasonably stop them seeking gen... be able to differentiate premiums according to ve...
...esearch suggests that cannabis, also known as mari...gies and autoimmune disorders that occur when bod... Researchers led by Andreas Zimmer, at the U.... However, the researchers warned that peo...
... on Thursday received 15 million dollars worth of ...nment to bolster its fight against HIV and AIDS, o...ates will provide Zimbabwe with anti-retroviral dr...US government, which has frosty relations with the...
... TATA company, is in negotiations with Prof Vijay ...ttached to the University of Arkansas, to start p... the final stages. The deal is yet to be finalized...ter (HiDEC) and Neurosurgery Research Programme in...
...llion Euro research project, European Lifestyles a...for Europes four regional seas. As part o...rom 28 institutions from 15 European countries, fo...oss-cutting environmental issues: habitat change, ...
Other Medicine News:Health News:1,600 Roller Shoe Injuries Reported 2Health News:Should Genetic Information Be Disclosed to Insurers? 2Health News:Zimbabwe Receives 15m Dollars of AIDS Drugs from US 2Health News:Titan may Produce Glucose Watches Soon 2Health News:Dire Future Predicted for Europe's 4 Seas 2
(Date:11/23/2009)..., EXTON,Pa.,Nov.23/PRNewswire/--BioTrendsRese...M): Feraheme report,thesecondinamulti-phasesyndi...snewIVironproduct,Feraheme,throughthefirstsixmonth...quantitativeinformationfrom50uniqueNephrologistsan...ssesstrialanduseofFeraheme,obstaclestouse,reasonst...
(Date:11/23/2009)..., WALTHAM,Mass.,Nov.23/PRNewswire/--ProteonTh...studyofitsleadproduct,PRT-201,inend-stagerenaldise...graft(AVG)creation.TheAVGstudyrepresentsProteon,ss...iouslyannouncingtheinitiationofaPhase1/2studyofPRT...sfistula(AVF)creationearlierthisyear.Proteonalsoan...
(Date:11/23/2009)..., SOUTHSANFRANCISCO,Calif.,Nov.23/PRNewswire-...cedthatDr.TedW.LoveandDr.DavidC.U,Prichardhaveagre...ionoftheproposedmergerbetweenAnesivaandArcionThera...ervotescheduledtotakeplaceatthepreviouslyannounced...ecember3,2009at9:00a.m.PSTat400OysterPoint,Suite10...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Brown professor continues debate over recovered memory 50995 1Brown professor continues debate over recovered memory 50995 2Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 1Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 2Fewer Shots Could Still Protect Kids From Pneumonia 50989 1Fewer Shots Could Still Protect Kids From Pneumonia 50989 2
... Risk Based on Clinical Data, Preventive Measur...WALTHAM, Mass., July 22 Interleukin Genetics,Inc....nhanced test report,format and information package...test is currently marketed under the brand name Ge...y. The new report will include quantified risk,inf...
...rd Clinical Trial,Service Unit and Epidemiological...generating results of the SEAS trial of ezetimibe ...results from the SHARP and,IMPROVE-IT trials of ez...the relevant regulatory authorities, independently...esting trials (SHARP and IMPROVE-IT) contain about...
Other Medicine Technology:Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 2Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 3
7.75mm diameter Corneal Trephine Blades
6.5mm diameter Corneal Trephine Blades
5.5mm diameter Corneal Trephine Blades
7.50mm Open Trephine Handle
Medicine Products: